43P: Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer
Dieter Stevens, Joline Ingels, Elisabeth Brabants, Sandra Van Lint et autres
be (code pays fourni par la source)